More about
Polymyalgia Rheumatica
News
October 04, 2019
2 min read
Save
Managing adverse events from checkpoint inhibitors in a ‘data-free zone’
SAN DIEGO — Increasing use of checkpoint inhibitors in cancer therapy is leading to an uptick in immune-related adverse events for rheumatologists to manage, according to a presentation at the Congress of Clinical Rheumatology West.